Intrinsic β-catenin signaling suppresses CD8+ T-cell infiltration in colorectal cancer
Colorectal cancer is the third most common cancer worldwide and shows resistance to immune checkpoint inhibitors which have been demonstrated to be effective in many other types of cancers. Pre-existing T-cell response in tumor microenvironment often determines the therapeutic benefit of immune chec...
Main Authors: | Junli Xue, Xuetao Yu, Liqiong Xue, Xiaoxiao Ge, Wei Zhao, Wei Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332219303567 |
Similar Items
-
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
by: Emilie Picard, et al.
Published: (2020-03-01) -
Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells
by: Xiu-Man Zhou, et al.
Published: (2018-11-01) -
Corrigendum to “Intrinsic β-catenin signaling suppresses CD8 + T-cell infiltration in colorectal cancer” [Biomed. Pharmacother. 115 (May) (2019) 108921]
by: Junli Xue, et al.
Published: (2020-12-01) -
FOLFOX Chemotherapy Ameliorates CD8 T Lymphocyte Exhaustion and Enhances Checkpoint Blockade Efficacy in Colorectal Cancer
by: Yue Guan, et al.
Published: (2020-04-01) -
β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer
by: Caihong Wang, et al.
Published: (2020-01-01)